ARFGEF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.528200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.891200E-01
Normal-vs-Stage2
8.547600E-01
Normal-vs-Stage3
5.161800E-01
Normal-vs-Stage4
7.388000E-01
Stage1-vs-Stage2
9.628200E-01
Stage1-vs-Stage3
3.106000E-01
Stage1-vs-Stage4
5.341200E-01
Stage2-vs-Stage3
2.555800E-01
Stage2-vs-Stage4
6.003800E-01
Stage3-vs-Stage4
6.340000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.547800E-01
Normal-vs-AfricanAmerican
8.743600E-01
Normal-vs-Asian
8.953800E-01
Caucasian-vs-AfricanAmerican
9.977200E-01
Caucasian-vs-Asian
5.210600E-01
AfricanAmerican-vs-Asian
7.323600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.556200E-01
Normal-vs-Female
8.463400E-01
Male-vs-Female
9.671400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.519200E-01
Normal-vs-Age(41-60Yrs)
6.518000E-01
Normal-vs-Age(61-80Yrs)
9.259800E-01
Normal-vs-Age(81-100Yrs)
9.858000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.560800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.213800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.635600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.624400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.800200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.345400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.830000E-01
Normal-vs-Daily Drinker
8.205200E-01
Normal-vs-Weekly Drinker
8.558600E-01
Normal-vs-Occasional Drinker
4.507000E-01
Normal-vs-Social Drinker
9.357200E-01
Non Drinker-vs-Daily Drinker
5.557400E-01
Non Drinker-vs-Weekly Drinker
7.101600E-01
Non Drinker-vs-Occasional Drinker
9.633700E-02
Non Drinker-vs-Social Drinker
8.446400E-01
Daily Drinker-vs-Weekly Drinker
4.840000E-01
Daily Drinker-vs-Occasional Drinker
5.202400E-01
Daily Drinker-vs-Social Drinker
7.185800E-01
Weekly Drinker-vs-Occasional Drinker
1.357150E-01
Weekly Drinker-vs-Social Drinker
6.546600E-01
Occasional Drinker-vs-Social Drinker
2.209600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.323600E-02
Normal-vs-Grade 2
3.659700E-03
Normal-vs-Grade 3
1.881190E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.972400E-01
Grade 1-vs-Grade 3
2.509600E-01
Grade 1-vs-Grade 4
7.323600E-02
Grade 2-vs-Grade 3
3.832200E-02
Grade 2-vs-Grade 4
3.659700E-03
Grade 3-vs-Grade 4
1.881190E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.033400E-01
Normal-vs-NonDiabetic
8.942800E-01
Diabetic-vs-NonDiabetic
9.752600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.522200E-01
Normal-vs-NoPancreatitis
9.106000E-01
Pancreatitis-vs-NoPancreatitis
4.443000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.017400E-01
Normal-vs-N1
8.400400E-01
N0-vs-N1
8.592600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.325000E-01
Normal-vs-TP53-NonMutant
8.853200E-01
TP53-Mutant-vs-TP53-NonMutant
8.341500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
